Dexmedetomidine in the Treatment of Agitation Associated With Schizophrenia

Clinical trial NCT04268303 · COMPLETED

Trial details

NCT number: NCT04268303
Sponsor: BioXcel Therapeutics Inc
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Agitation Schizophrenia Schizo Affective Disorder Schizoaffective Disorder Schizophreniform Disorders

Start date: 2020-01-24
Primary completion: 2020-05-06
Enrollment: 380

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.